Advertisement
12/08/2022

ANI obtains FDA nod for generic Prozac

The medication treats depression, panic attacks, obsessive-compulsive disorder, bulimia and a severe form of premenstrual syndrome (premenstrual dysphoric disorder).
Sandra Levy
Senior Editor
Sandra Levy profile picture

ANI has received the Food and Drug Administration’s clearance for fluoxetine oral solution, 20 mg/5 ml, which is the generic of Eli Lilly's Prozac.

The medication treats depression, panic attacks, obsessive-compulsive disorder, bulimia and a severe form of premenstrual syndrome (premenstrual dysphoric disorder).

Fluoxetine oral solution has a market value of approximately $14.6 million, according to IQVIA.

[Read more: FDA gives ANI green light for Cortrophin Gel]

“We continue to strengthen our generics business with new product launches, and laud the efforts of our R&D team in helping the company fulfill its ongoing commitment to provide affordable generic alternatives to customers and patients in need,” said Nikhil Lalwani, president and CEO of ANI.

    Advertisement
    Advertisement